NCT04783753 - Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

June 28, 2021

Study Completion Date

July 9, 2021

Conditions

Hepatitis B

Interventions

DRUG

EDP-514

Subjects will receive EDP-514 on Days 1 and 14

DRUG

EDP-514

Subjects will receive EDP-514 on Days 1 and 23

DRUG

EDP-514

Subjects will receive EDP-514 on Days 1 and 8

DRUG

Itraconazole

Subjects will receive itraconazole QD for 14 days

DRUG

Carbamazepin

Subjects will receive carbamazepine BID for 23 days

DRUG

Quinidine

Subjects will receive quinidine BID for 8 days

Trial Locations (1)

Pharmaceutical Research Association, Lenexa